Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05186792
Other study ID # CT 253889
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 5, 2019
Est. completion date October 5, 2019

Study information

Verified date December 2019
Source Cwm Taf University Health Board (NHS)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine if the presence of Mycoplasma hominis bacteria is associated with Bacterial vaginosis (BV), non-gonococcal urethritis (NGU) or vaginitis in patients attending sexual health clinic. Patients were participants of the MYCO WELL D-ONE study. Ethics for this follow-on pathway-to-portfolio study (IRAS:253889) is now approved by NRES and HCRW. The important primary aim of this study is to determine if Mycoplasma hominis (M.hominis) is associated with BV, NGU and vaginitis in the genitourinary system of patients or if they are bacterial commensals. This is important proof of concept work. The secondary aim for this research is to determine if there are clinical and social parameters that are associated with Mycoplasma infection. Preliminary analysis of 100 patients yielded pilot data suggesting M.hominis is strongly associated with BV, NGU and vaginitis. We aim to consolidate these findings by expansion to 1000 patients from our completed MYCOWELL D-ONE study.


Description:

The clinical study site is The Department of Sexual Health, Dewi Sant Hospital, Cwm Taf University Health Board. This study will retrospectively examine the clinical notes of consented participants (IRAS project ID:253889) in the MYCO WELL D-ONE study (IRAS project ID:230693). Notes will be identified by the sexual health clinic number. The clinic proforma records the following parameters: 1. Gender the patient identifies with 2. Age of the patient when the MYCO WELL D-ONE study sample collected 3. Symptoms and signs that were recorded in the patient notes e.g. BV/NGU 4. Previous sexually transmitted infections diagnosed 5. Drug history 6. Treatments the patient received 7. Sexual history e.g. type of sexual activity On completion, he parameters associated with positive M.hominis result; bacteria load quantification/antimicrobial resistance) and statistical analysis will be examined as below. I Statistical analysis This will be performed on anonymised data. The primary outcome measure of this study is to determine if M.hominis is associated with BV, NGU and vaginitis in the genitourinary system of patients or if it is a bacterial commensal. The secondary outcome for this research is to determine if there are clinical and social parameters that are associated with M.hominis infection.


Recruitment information / eligibility

Status Completed
Enrollment 1000
Est. completion date October 5, 2019
Est. primary completion date October 5, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 16 Years to 100 Years
Eligibility Inclusion Criteria: - Sexually active participants aged 18 to 100 years - Participants can give informed consent in writing. Exclusion Criteria: - Patients who have been sexually assault. - Participants who cannot give informed consent in writing.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Test:mycoplasma
Retrospective analysis of records of recruits to a previous mycoplasma study.

Locations

Country Name City State
United Kingdom Cwm Taf Morgannwg University Health board Pontypridd

Sponsors (2)

Lead Sponsor Collaborator
Cwm Taf University Health Board (NHS) Cardiff University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary M. hominis and disease Number of symptomatic participants with Mycoplasma infections 6 months
Secondary M.hominis and drug use Number of patients with Mycoplasma infection and drug use 6 months
Secondary M.hominis and number of sexual contacts Number of patients with Mycoplasma infection who have more than 2 sexual partners in 3 months 6 months
Secondary M.hominis and miscarriage Number of patients with Mycoplasma infection who have a history of miscarriage 6 months
Secondary M.hominis and abortion Number of patients with Mycoplasma infection who have a history of abortion in the last 5 years 6 months
Secondary M.hominis and anal sex Number of patients with Mycoplasma infection who perform anal sex 6 months
Secondary M.hominis and unprotected sex Number of patients with Mycoplasma infection who have sex without condom use 6 months
Secondary M.hominis and contraception Number of patients with Mycoplasma infection while taking hormonal contraception 6 months
Secondary M.hominis and men who have sex with men Number of patients with Mycoplasma infection and are men that have sex with men 6 months
Secondary M.hominis and commercial sex workers Number of patients with Mycoplasma infection who have sex with commercial sex workers 6 months
Secondary M.hominis and chemsex Number of patients with Mycoplasma infection who have chemsex 6 months
See also
  Status Clinical Trial Phase
Completed NCT04182230 - UROGEN WELL D-ONE : Evaluation of a Novel Diagnostic for Sexually Transmitted Bacterial Infections
Completed NCT02552914 - Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of STIs
Recruiting NCT05391035 - The Antibiotic Guardian Study- Clinical Evaluation of a Novel, Rapid Diagnostic for Gonorrhoea and Mycoplasma Infections.
Terminated NCT03684668 - Psychoeduc Interv. Through Meta-universes on Condom's Use Self - Efficacy and Sexual Behavior in Students of UAChile N/A
Completed NCT04491422 - Same-Day PrEP Initiation and Sexual Health for Transgender Women N/A
Active, not recruiting NCT04036396 - Prevention Support for People Leaving Jail N/A
Completed NCT04036318 - Evaluation of Presumptive Periodic Treatment (PPT) of Sexually Transmitted Infections (STIs)
Completed NCT05307991 - Integrating Enhanced HIV PrEP Into a STI Clinic in Lilongwe
Active, not recruiting NCT04664998 - Alignment of PrEP Use With HIV Risk in Young Women and Men Phase 4
Recruiting NCT04552171 - Game Plan: Efficacy of a Brief, Web-based Intervention on Alcohol Use and Sexually-transmitted Infections N/A
Not yet recruiting NCT06188442 - Superiority of On-demand PrEP Versus PEP on Using Doxycycline for Preventing STI in MSM Phase 4
Not yet recruiting NCT04244994 - Self-taken Penile Meatal Swabs for Chlamydia, Gonorrhoea and Mycoplasma Genitalium Detection N/A